California Public Employees Retirement System’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-84,400
Closed -$788K 2991
2021
Q1
$788K Sell
84,400
-7,465
-8% -$59.2K ﹤0.01% 2657
2020
Q4
$441K Sell
91,865
-1,700
-2% -$8.29K ﹤0.01% 2983
2020
Q3
$375K Buy
93,565
+11,065
+13% +$53.4K ﹤0.01% 2948
2020
Q2
$379K Buy
82,500
+54,300
+193% +$243K ﹤0.01% 2867
2020
Q1
$92K Sell
28,200
-7,107
-20% -$27.3K ﹤0.01% 3130
2019
Q4
$152K Buy
+35,307
New +$125K ﹤0.01% 3190

Other funds holding NAGE

California Public Employees Retirement System's NAGE Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Niagen Bioscience (NAGE) in Q2 2021, closing a stake of 84,400 shares — an estimated $788K sold.

California Public Employees Retirement System first reported a position in NAGE in Q4 2019 and held it in 6 quarters. The position peaked at $788K in Q1 2021. 101 funds tracked by Wall St. Rank hold NAGE as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Niagen Bioscience position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 84,400 Niagen Bioscience shares in Q2 2021, an estimated $788K.
  • California Public Employees Retirement System first reported a position in Niagen Bioscience in Q4 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's Niagen Bioscience position peaked at $788K in Q1 2021.
  • 101 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.